Kevin Anderson
genetics
Greiner Bio-One Co Ltd
China
Biography
Kevin Anderson is a Sr. Principal Scientist in the Analytical Biochemistry group at Seattle Genetics where he is responsible for method development and characterization of recombinant monoclonal antibodies and antibody drug conjugates. In this capacity he has served as the analytical lead on both early and late stage programs, including brentuximab vedotin. Prior to working in the biotechnology industry, he received a Ph.D. degree in Biochemistry from the University of Delaware and was a Senior Fellow at the University of Washington's Bioengeneering department.
Research Interest
ecombinant monoclonal antibodies and antibody drug conjugates.
